Gilead: FDA OKs Trodelvy
The FDA has approved Gilead's Trodelvy for two indications, one for monotherapy and the other for combination with pembrolizumab.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.